Search online for anything about menopause and you’ll find two kinds of voices, both shouting at the same volume. One says hormones are poison. The other says every woman simply must take them. And there you are, somewhere in the middle, with a body that has suddenly started doing things nobody warned you about.

Let’s work it out calmly. No camps, no scaremongering, only what the research genuinely shows. Because just like that expensive jar of collagen, the honest truth sits somewhere in the middle, and that’s exactly why it’s worth telling.

One thing first, and I mean it: this isn’t personal medical advice. It’s a map, not a route. Your route is a conversation with your GP or gynaecologist.

What is actually happening

Most people think: “The ovaries stop making oestrogen, so that’s the end of it.” But it isn’t that simple, and the real story is far more beautiful.

During your fertile years, your ovaries are the main power station. They produce large amounts of oestradiol, the most powerful natural oestrogen, and it flows to your whole body: brain, bones, blood vessels, skin, muscles, bladder, immune system. Everything is used to it. It’s the electricity the whole house runs on.

Then the ovaries don’t suddenly run dry; they slowly work through their supply of eggs. And that in-between stretch, the perimenopause, is often the hardest part of all. Not a tidy decline, but wild swings: towering oestrogen peaks one week, almost nothing the next. For the brain, those swings are often harder to handle than a steady low level. In the Penn Ovarian Aging Study, which followed women for nine years, hot flushes, joint pain and low mood all increased as the transition progressed, and the symptoms tracked the fluctuations in oestradiol, not just its level.

And after menopause? Here’s what too few people know. Your body doesn’t end up without oestrogen, it simply changes supplier. In countless places (fat tissue, bone, the walls of your blood vessels, your brain) sits an enzyme, aromatase, that can convert building blocks from your adrenal glands into oestrogen. No longer one great current running through the body, but locally, on the spot, exactly where it’s needed. The main power station closes; small local generators take over. The lights stay on, the whole grid just has to be retuned.

Or, if you like orchestras: the great symphony orchestra retires, and a chamber ensemble takes over. Less brass, less volume. But there’s still music.

Why the transition years sometimes feel harder than the years after

This explains a riddle many women recognise: why do I often feel worse in the middle of the transition than a few years later?

For decades your brain has heard one message: “my normal is this level.” When that level falls away, and especially while it’s still bouncing in every direction, the temperature control, the sleep centres and the neurotransmitters all have to relearn what “normal” means. That’s called recalibrating, and it takes time. After a few years a new balance usually settles in. Not the same as before. But a balance.

That may be the most reassuring sentence in this whole piece: your body isn’t broken. It’s finding a new setting.

Hot flushes: a thermostat gone haywire

Everyone knows the picture of a hot flush, but almost nobody knows what sits underneath it. Deep in your hypothalamus is a kind of thermostat. A little cluster of nerve cells with an impossible name — KNDy neurons, helps set that thermostat, and those cells are sensitive to oestrogen. When the oestrogen falls away, that cluster is thrown off and your “comfort zone” for temperature suddenly becomes wafer-thin.

The result: a minuscule rise in body temperature, which you wouldn’t even have noticed before, is now read as an emergency. Your body reacts as if someone secretly cranked the heating up to 30, and panics by throwing all the windows open, flushing, sweating, dumping heat. Not because something is wrong, but because the thermostat is set too sharply.

The lovely part is that we now understand this so well that there’s a new kind of medicine aimed precisely at that brain circuit rather than at your hormones. In large trials, such a drug (a blocker of the neurokinin-3 receptor) reduced the number and severity of hot flushes clearly more than a placebo did. For the first time, we’re treating the cause in the brain, not the hormones around it.

The quiet complaint: joints and muscles

Ask anyone about menopause and you’ll hear: hot flushes, night sweats, mood swings. But a great many women say something else: why did nobody tell me my joints would suddenly start to ache?

“I woke up one morning as if I’d aged ten years overnight.” That’s a sentence menopause specialists and rheumatologists hear endlessly. And it isn’t imagination. In that same nine-year study, “aches, joint pain and stiffness” were among the symptoms that rose through the transition.

Why? Because oestrogen does far more than run reproduction. There are oestrogen receptors inside your cartilage, in the very cells that maintain your joints. Oestrogen is also mildly anti-inflammatory, and it influences how your brain processes pain. Take it away, and slumbering vulnerabilities can suddenly surface.

The most convincing evidence comes from an unintended experiment. For some types of breast cancer, women are given drugs (aromatase inhibitors) that push oestrogen very low. One of the best-known side effects? A pronounced joint-pain syndrome. Remove the oestrogen, and the joints protest. That’s no coincidence.

And then there’s a nasty vicious circle. Night sweats disturb your sleep, and sleep loss measurably lowers your pain threshold. Worse sleep → more pain → worse sleep. A loop that feeds itself.

An important nuance, so you don’t panic unnecessarily: this isn’t automatically arthritis. Often the complaints begin without any structural damage in the joint, they’re more like hormonal and inflammatory changes. The joint isn’t worn out. The setting has changed.

What can you do yourself?

This is where many women scroll to: lovely story, but what can I do? And I have to disappoint you with a truth that’s actually freeing: there is no miracle food. If there were, it would already be in a fifty dollar jar, and we covered that last time.

But there are things that consistently help, without glamour but with evidence.

Sleep first. So many complaints are amplified by poor sleep — pain, irritability, concentration, appetite. A cool bedroom, fixed hours, a little less alcohol: not spectacular, but effective.

Movement as medicine — and especially strength. Of all lifestyle measures, moving has the broadest payoff. Resistance training measurably improves bone density at the hip and spine, exactly the places that become vulnerable after menopause. Think of it as an investment in the bones of your future self. Plus: more muscle, better balance, a brighter head.

Food without the hype. Enough protein becomes more important than before (for keeping muscle), calcium and vitamin D for your bones (vitamin D is often worth attention at our latitude), and as a pattern the Mediterranean kitchen — olive oil, vegetables, pulses, fish, nuts — has more evidence behind it than any “menopause diet” going. And be sceptical of supplements: in good research, omega 3 and yoga, for instance, did no better than placebo for the flushes themselves. That doesn’t make yoga worthless — do move — but the advertising shouts louder than the evidence.

Hormone therapy: the most talked-about chapter

And now the subject that holds the most fear and confusion.

First, the facts, plainly. Hormone therapy is currently the most effective treatment for hot flushes and night sweats, and also for the dryness and bladder symptoms that come with the transition. It also protects against bone loss and fractures. That isn’t marketing; it’s the conclusion of the major menopause guidelines.

What do doctors actually give? For a woman without a womb, usually oestrogen alone. For a woman with a womb, oestrogen plus a progestogen, that second hormone protects the lining of the womb. (More on that shortly, because that’s exactly where part of the cancer story sits.)

One reassurance few people know: for local symptoms “down below” there’s vaginal oestrogen in a very low dose. In the large review of hormones and breast cancer, it was precisely that form that was not linked to increased risk. Local, low-dose, and reassuringly well studied.

“But won’t it give me cancer?”

This is the question beneath all the questions. And the honest answer is more nuanced than either camp would have you believe.

Breast cancer, combined therapy. Oestrogen plus a progestogen can, after several years of use, raise the risk of breast cancer a little. And you may take “a little” literally — let me put it in plain numbers. Imagine a group of women who start five years of hormone therapy at fifty. The large, worldwide re-analysis looked at what then happens to the number of breast cancers between the ages of fifty and seventy. It depends strongly on which therapy:

• Oestrogen with daily progestogen: roughly 1 extra case per 50 women.
• Oestrogen with progestogen taken less often: roughly 1 extra case per 70 women.
• Oestrogen on its own: roughly 1 extra case per 200 women.

So what does a number like that really mean? Out of every 50 (or 70, or 200) women, one develops a breast cancer she probably would not have had without the therapy — the other 49 (or 69, or 199) notice no difference. And it sits on top of the ordinary risk every woman already carries. So it is a real risk, but for most women a small one. And you can see at once how much the type of therapy matters.

And here it gets fascinating. Oestrogen alone is a completely different story from the combination. In the large randomised American trial, oestrogen alone (in women without a womb) was actually linked to less breast cancer and fewer deaths from it. Observational studies sometimes see a very small rise, the trial sees a fall, and honestly: experts are still debating this. But the simple slogan “oestrogen = breast cancer” is therefore wrong.

Womb cancer. Here’s the flip side. Oestrogen alone in a woman with a womb actually raises the risk of cancer of the womb lining. That’s why the progestogen is added: not as an afterthought, but as protection.

And the big numbers? When researchers followed those same women for eighteen years, hormone therapy was not linked to higher mortality, not overall, not from heart disease, not from cancer. That’s an important, reassuring footnote to all the headlines.

It comes down to timing. People used to think hormones always protected the heart. Too simple, it turned out. Now we think more carefully: start around the transition (under 60, within about ten years of your last period) and the balance is usually favourable. Start much later, and the benefit shrinks while the risk grows. In a trial where women were given oestradiol, it slowed artery furring only when started soon after menopause, not when begun ten years later. The right moment matters.

So the real message of this chapter isn’t a yes or a no. It’s: it depends — on the type, the dose, the duration, the route, the timing, and above all on you. This is tailored work. A conversation with your doctor, not a verdict from a blog.

And if you don’t want, or can’t take, hormones?

Good news: there’s more than hormones alone. Some antidepressants at a low dose reduced hot flushes in research by roughly half (against about 30% with placebo). There’s the new drug that acts directly on that thermostat circuit in the brain. And cognitive behavioural therapy measurably helped women sleep better and cope better with the symptoms. No miracle cures, but real options, ones you can weigh up with your doctor.

The deeper layer: why does menopause even exist?

Now a question you rarely hear, and one I find beautiful.

Almost all female mammals stay fertile until shortly before they die. Humans don’t. Women often live for decades after menopause, healthy, active, present. Evolutionarily, that’s strange. Why would nature pour so much energy into women who no longer have children?

One of the loveliest answers is called the grandmother hypothesis. The idea: older women were enormously valuable. By caring, feeding and passing on knowledge, they raised the survival odds of their grandchildren and the fertility of their daughters. So a long life after fertility wasn’t punished by evolution, but rewarded. Those decades aren’t a leftover, not a mistake of nature. They look like part of the design.

In other words: menopause may not be the end of something. It may be the beginning of a second physiological phase of life, a second act, in a different register, but with at least as much meaning.

In closing

The transition doesn’t play out in the ovaries alone. It plays out in your whole body, right down to the fingers you lift your morning coffee with. And it’s not a test of character. You don’t have to earn a medal for enduring.

Some women have barely any symptoms. Others genuinely need help. Both are normal. Good care doesn’t begin by asking whether symptoms “simply come with the territory”, but by asking how much they affect your life. If the answer is “a lot”, that’s a perfectly valid reason to seek help, from your GP or gynaecologist.

Your body isn’t broken. It’s recalibrating. And sometimes science can help you find that new balance a little sooner and a little more comfortably.

What might change if we saw menopause not as the ebbing-away of something, but as the start of a second act, one that nature, across all those millennia, has evidently made deliberate room for?

Related reading

• Collagen: does that expensive jar really work?
• Diets: what really works?
• Olive oil: liquid gold or liquid marketing?

---

Important: this article shares general science, not personal medical advice. Considering hormone therapy or another treatment, unsure about your symptoms, or taking medication? Talk to your GP or gynaecologist. They can look at your situation, your history and your risks, a blog can’t.

---

Sources

Scientific articles consulted via PubMed.

• The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767–794. https://doi.org/10.1097/GME.0000000000002028
• Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019;394(10204):1159–1168. https://doi.org/10.1016/S0140-6736(19)31709-X
• Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials. JAMA. 2020;324(4):369–380. https://doi.org/10.1001/jama.2020.9482
• Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials. JAMA. 2017;318(10):927–938. https://doi.org/10.1001/jama.2017.11217
• Hodis HN, Mack WJ, Henderson VW, et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine. 2016;374(13):1221–1231. https://doi.org/10.1056/NEJMoa1505241
• Simpson ER. Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology. 2003;86(3–5):225–230. https://doi.org/10.1016/s0960-0760(03)00360-1
• Freeman EW, Sammel MD, Lin H, et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstetrics & Gynecology. 2007;110(2 Pt 1):230–240. https://doi.org/10.1097/01.AOG.0000270153.59102.40
• Miragem AA, Homem de Bittencourt PI. Nitric oxide–heat shock protein axis in menopausal hot flushes. Human Reproduction Update. 2017;23(5):600–628. https://doi.org/10.1093/humupd/dmx020
• Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. The Lancet. 2023;401(10382):1091–1102. https://doi.org/10.1016/S0140-6736(23)00085-5
• Tankó LB, Søndergaard B-C, Oestergaard S, Karsdal MA, Christiansen C. An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric. 2008;11(1):4–16. https://doi.org/10.1080/13697130701857639
• Ozcivit IB, Erel CT, Durmusoglu F. Can fibromyalgia be considered a characteristic symptom of climacterium? Postgraduate Medical Journal. 2023;99(1170):244–251. https://doi.org/10.1136/postgradmedj-2021-140336
• Burstein HJ. Aromatase inhibitor-associated arthralgia syndrome. The Breast. 2007;16(3):223–234. https://doi.org/10.1016/j.breast.2007.01.011
• Chang JR, Fu S-N, Li X, et al. The differential effects of sleep deprivation on pain perception in individuals with or without chronic pain: a systematic review and meta-analysis. Sleep Medicine Reviews. 2022;66:101695. https://doi.org/10.1016/j.smrv.2022.101695
• Shojaa M, von Stengel S, Kohl M, Schoene D, Kemmler W. Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a systematic review and meta-analysis. Osteoporosis International. 2020;31(8):1427–1444. https://doi.org/10.1007/s00198-020-05441-w
• Reed SD, LaCroix AZ, Anderson GL, et al. Lights on MsFLASH: a review of contributions. Menopause. 2020;27(4):473–484. https://doi.org/10.1097/GME.0000000000001461
• Hawkes K, Coxworth JE. Grandmothers and the evolution of human longevity: a review of findings and future directions. Evolutionary Anthropology. 2013;22(6):294–302. https://doi.org/10.1002/evan.21382
• Hawkes K, O’Connell JF, Blurton Jones NG, Alvarez H, Charnov EL. Grandmothering, menopause, and the evolution of human life histories. Proceedings of the National Academy of Sciences. 1998;95(3):1336–1339. https://doi.org/10.1073/pnas.95.3.1336